Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 CJC-1295 Stack: Protocol Comparison

Primary Mechanism VEGF receptor upregulation, localized angiogenesis GHRH receptor agonism, extended GH pulse duration BPC-157 creates vascular scaffolding; CJC-1295 provides systemic IGF-1 to drive collagen maturation BPC-157 peaks 48–72 hours; CJC-1295 raise

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • VEGF receptor upregulation, localized angiogenesis
  • GHRH receptor agonism, extended GH pulse duration
  • BPC-157 creates vascular scaffolding; CJC-1295 provides systemic IGF-1 to drive collagen maturation
  • BPC-157 peaks 48–72 hours; CJC-1295 raises IGF-1 within 24–48 hours
  • The mechanisms are sequential. BPC-157 without elevated IGF-1 plateaus around week 4
  • Dosing Frequency
  • Daily or twice daily (250–500mcg per dose)
  • Twice weekly (1–2mg total per week split into two doses)
  • Daily BPC-157 sustains angiogenesis; twice-weekly CJC-1295 maintains elevated IGF-1 throughout
  • BPC-157 requires consistent daily dosing; CJC-1295 half-life allows twice-weekly administration
  • Over-dosing CJC-1295 doesn't increase IGF-1 further. Twice weekly is the ceiling
  • Injection Site
  • Subcutaneous near injury site (within 2–3 inches)
  • Subcutaneous, any site (abdominal or thigh common)
  • Localized BPC-157 concentrates repair; systemic CJC-1295 operates body-wide
  • BPC-157 site-specific; CJC-1295 systemic regardless of injection site
  • Inject BPC-157 near the injury. CJC-1295 site doesn't matter
  • Half-Life
  • ~4 hours (short)
  • 6–8 days (extended via DAC modification)
  • BPC-157's short half-life requires frequent dosing; CJC-1295's long half-life sustains IGF-1 across the week
  • BPC-157 clears within hours; CJC-1295 remains active for 6–8 days
  • The half-life difference is why the stack works. One local, one systemic
  • Timeline to Measurable Outcomes
  • Angiogenesis visible in 7–14 days in rodent models
  • IGF-1 elevation measurable within 48–72 hours of first dose
  • Collagen remodeling requires both angiogenesis (BPC-157) and IGF-1 (CJC-1295). Expect 8–12 weeks for structural tissue changes
  • Early subjective improvement (pain reduction) in 2–3 weeks; objective strength gains in 8+ weeks
  • Don't expect miracles in week 2. Tissue remodeling is a 12-week process
More references

Related material